IP Library Granted Patent US 12692559
Granted Patent B2
US 12692559 · App. 18/170,064 · Granted Jul 28, 2026

Primer composition for recombinase-polymerase amplification reaction for rapid diagnosis of Israeli acute bee paralysis virus and use thereof

Inventors: Eui Joon Kil (Andong-si, KR); Chul Eui Jung (Seoul, KR); Man Cheol Son (Gyeongsangbuk-do, KR)
Assignee: Andong National University Industry-Academic Cooperation Foundation
C12Q1/70C12Q1/6844
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12692559
App. No.
18/170,064
Granted
Jul 28, 2026
Kind
B2
Abstract

Proposed is a primer composition for a recombinase-polymerase amplification reaction for rapid diagnosis of Israeli acute paralysis virus and use thereof. A genomic RNA of Israeli acute paralysis virus (IAPV) is isolated from honey bees to analyze a nucleotide sequence of IAPV, and a primer pair capable of being detected by a recombinase-polymerase amplification method was prepared based on the IAPV RNA sequence. In addition, the optimal conditions of the prepared primer pair were confirmed, and it was confirmed that the genomic RNA of IAPV could be rapidly detected and diagnosed.

Claims (17)

1 . A primer set for detecting Israeli acute paralysis virus (IAPV), the primer set consisting of a forward primer consisting of the nucleotide sequence of SEQ ID NO: 1 and a reverse primer consisting of the nucleotide sequence of SEQ ID NO: 2,

wherein the primer set generates an amplification product having a length of 191 base pairs from a target nucleic acid comprising the nucleotide sequence of SEQ ID NO: 11 in a recombinase polymerase amplification reaction performed at a temperature of 24° C. for 45 minutes.

2 . A composition for detecting Israeli acute paralysis virus (IAPV), the composition comprising:

a primer set consisting of a forward primer consisting of the nucleotide sequence of SEQ ID NO: 1 and a reverse primer consisting of the nucleotide sequence of SEQ ID NO: 2,

wherein the primer set generates an amplification product having a length of 191 base pairs from a target nucleic acid comprising the nucleotide sequence of SEQ ID NO: 11 in a recombinase polymerase amplification reaction performed at a temperature of 24° C. for 45 minutes.

3 . The composition of claim 2 , comprising 0.5 to 3.5 μl of the primer set.

4 . The composition of claim 2 , comprising 0.5 to 4.0 μl of MgOAc.

5 . The composition of claim 2 , further comprising a DNA polymerase for a recombinase-polymerase amplification reaction, dNTPs, a reaction buffer, and distilled water.

6 . A method for detecting Israeli acute paralysis virus (IAPV), the method comprising:

providing a bee specimen;

grinding the bee specimen to form a ground bee specimen;

diluting the ground bee specimen in sterilized distilled water to form a diluted bee specimen;

mixing the diluted bee specimen with a DNA extraction solution at a volume ratio of 1:1 to form an extraction mixture;

heating the extraction mixture at 95° C. for 5 minutes to form a heated mixture;

separating a supernatant from the heated mixture;

amplifying Israeli acute paralysis virus RNA contained in the supernatant in a recombinase polymerase amplification reaction performed at 24° C. for 45 minutes using a forward primer consisting of the nucleotide sequence of SEQ ID NO: 1 and a reverse primer consisting of the nucleotide sequence of SEQ ID NO: 2 to generate an amplification product having a length of 191 base pairs; and

confirming the amplification product by gel electrophoresis.